| |
| |
|
| Insider
Information: |
Viret Jean-Frederic |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
71,984 |
|
|
Indirect Shares
|
500 |
|
|
| Direct
Value |
$126,268 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
72,484 |
|
|
| Total
Value |
$126,268 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anesiva Inc |
ANSVQ |
Officer |
2008-03-01 |
6,041 |
2008-03-01 |
500 |
Premium* |
|
|
Diadexus Inc |
DDXS |
Chief Financial Officer |
2014-04-28 |
4,648 |
2013-03-27 |
0 |
Premium* |
|
|
Coherus Biosciences, Inc. |
CHRS |
Chief Financial Officer |
2021-02-01 |
61,295 |
2016-03-28 |
0 |
Premium* |
|
|
Ngm Biopharmaceuticals Inc |
NGM |
|
2024-04-05 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NGM |
Ngm Biopharmaceuticals In... |
Chief Financial Officer |
• – – |
2024-04-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,038) |
0 |
0 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
Chief Financial OfficerOfficer |
• – – |
2023-11-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38 |
|
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
AS |
$21.55 |
$159,513 |
D/D |
(7,402) |
61,295 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
OE |
$10.05 |
$74,390 |
D/D |
7,402 |
68,697 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-25 |
4 |
AS |
$19.00 |
$920,736 |
D/D |
(46,144) |
61,295 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-25 |
4 |
OE |
$10.05 |
$402,000 |
D/D |
40,000 |
107,439 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
67,439 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-01-10 |
4 |
D |
$18.18 |
$74,174 |
D/D |
(4,080) |
36,189 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-11-17 |
4 |
OE |
$13.50 |
$20,250 |
D/D |
1,500 |
40,269 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-11-17 |
4 |
AS |
$17.49 |
$34,896 |
D/D |
(1,995) |
38,769 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-10-14 |
4 |
AS |
$19.00 |
$116,736 |
D/D |
(6,144) |
40,423 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-05-20 |
4 |
AS |
$17.66 |
$22,569 |
D/D |
(1,278) |
46,567 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-02-19 |
4 |
AS |
$22.33 |
$70,552 |
D/D |
(3,159) |
46,841 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-02-19 |
4 |
OE |
$10.05 |
$31,748 |
D/D |
3,159 |
50,000 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-15 |
4 |
AS |
$19.67 |
$125,424 |
D/D |
(6,318) |
46,841 |
0 |
% |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-15 |
4 |
OE |
$10.05 |
$63,496 |
D/D |
6,318 |
53,159 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,615 |
46,841 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-01-10 |
4 |
D |
$17.73 |
$125,475 |
D/D |
(7,077) |
15,591 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-11-20 |
4 |
AS |
$19.59 |
$61,872 |
D/D |
(3,159) |
3,303 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-11-20 |
4 |
OE |
$10.05 |
$31,748 |
D/D |
3,159 |
6,462 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-11-18 |
4 |
AS |
$18.88 |
$58,757 |
D/D |
(3,112) |
3,303 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-10-18 |
4 |
AS |
$19.02 |
$26,400 |
D/D |
(1,388) |
6,385 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-10-16 |
4 |
AS |
$19.00 |
$60,021 |
D/D |
(3,159) |
7,773 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-10-16 |
4 |
OE |
$10.05 |
$31,748 |
D/D |
3,159 |
10,932 |
0 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
Chief Financial Officer |
• – – |
2019-09-18 |
4 |
AS |
$20.44 |
$64,560 |
D/D |
(3,159) |
8,513 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
